Jianling Xie

Dr

  • 614 Citations
  • 13 h-Index
20092019
If you made any changes in Pure these will be visible here soon.

Personal profile

Public Profile

From the beginning of my PhD, my research interests have been mainly focused on delineating the cellular signalling pathways involving the mechanistic target of rapamycin (mTOR) complexes (mTORCs), which are multisubunit protein kinases. By regulating the protein synthesis machinery, mTORC1 serve as master controllers of cell growth, proliferation, survival and migration. After joining Professor Proud’s lab in Southampton, my work focused on two protein kinases highly related to the mTORC1 signalling pathways, especially the role of eukaryotic elongation factor 2 kinase (eEF2K) and the mitogen-activated protein kinases (MAPK)-interacting kinases (MNKs) in regulating protein synthesis. Stemming from those studies, my research interest has now evolved towards studying the role of MNKs in the propagation of tumour cells. Deregulation of the MAPKs and the MNKs signalling has been closely implicated in tumorigenesis and development. Genes implicated in the MAPK pathway (i.e. Ras, B-Raf and MEK) are well known to be oncogenic whose mutations have been commonly found in cancer patients and contribute to cancer progression. Indeed, inhibitors to the MAPK pathway have attracted a very high level of interest in academia and the pharmaceutical industry during the last decades.

Education / Academic qualification

PhD, University of Leicester

1 Oct 200813 Jul 2012

Masters, University of Leicester

1 Oct 200730 Sep 2008

Keywords

  • QP Physiology
  • RS Pharmacy and materia medica

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

  • 614 Citations
  • 13 h-Index
  • 22 Article
  • 7 Review article
1 Citations

Design, synthesis and activity of Mnk1 and Mnk2 selective inhibitors containing thieno[2,3-d]pyrimidine scaffold

Jin, X., Merrett, J., Tong, S., Flower, B., Xie, J., Yu, R., Tian, S., Gao, L., Zhao, J., Wang, X., Jiang, T. & Proud, C. G. 15 Jan 2019 In : European Journal of Medicinal Chemistry. p. 735-751 17 p.

Research output: Research - peer-reviewArticle

The MAP kinase-interacting kinases (MNKs) as targets in oncology

Xie, J., Merrett, J. E., Jensen, K. B. & Proud, C. G. 2019 (Accepted/In press) In : Expert Opinion on Therapeutic Targets.

Research output: Research - peer-reviewArticle

1 Citations

Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis

Xie, J., Shen, K., Lenchine, R. V., Gethings, L. A., Trim, P. J., Snel, M. F., Zhou, Y., Kenney, J. W., Kamei, M., Kochetkova, M., Wang, X. & Proud, C. G. 1 May 2018 In : International Journal of Cancer. 142, 9, p. 1865-1877 13 p.

Research output: Research - peer-reviewArticle

Who does TORC2 talk to?

Xie, J., Wang, X. & Proud, C. G. 24 May 2018 In : Biochemical Journal. 475, 10, p. 1721-1738 18 p.

Research output: Research - peer-reviewReview article